This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Debate: Lung Cancer Screening Should Be Limited to Those Recommended by the ACCP Lung Cancer Screening Guidelines
Wood D, Farjah F, D'Amico TA, Detterbeck FC. Debate: Lung Cancer Screening Should Be Limited to Those Recommended by the ACCP Lung Cancer Screening Guidelines. January 2019. doi:10.25373/ctsnet.7450940.
Filmed at the 2018 STS Annual Meeting in Fort Lauderdale, Florida, Douglas Wood of the University of Washington in Seattle moderates a debate on the criteria that should be used to select which patients should undergo lung cancer screening. Dr Wood is joined by Farhood Farjah of the University of Washington, Thomas D'Amico of Duke University in Durham, North Carolina, and Frank Detterbeck of Yale University in New Haven, Connecticut. They discuss the screening guidelines from the American College of Chest Physicians (ACCP) and the National Comprehensive Cancer Network (NCCN), the differences between these guidelines, and the availability of risk calculators. To finish, Dr Wood asks each panel member how they would cover lung cancer screening in the US if they were Senior Medicare Administrator for a day.